发明名称 Compositions and Methods for the Production of Pyrimidine and Pyridine Compounds with BTK Inhibitory Activity
摘要 The present invention provides novel pyrimidine and pyridine compounds according to Formula (I), Formula (II), Formula (III), Formula (IV) and Formula (V) their manufacture and use for the treatment of hyperproliferative diseases including, but not limited to, cancer, lupus, allergic disorders, Sjogren's disease and rheumatoid arthritis. In preferred embodiments, the present invention describes irreversible kinase inhibitors including, but not limited to, inhibitors of Bruton's tyrosine kinase.
申请公布号 US2014162983(A1) 申请公布日期 2014.06.12
申请号 US201214112428 申请日期 2012.06.10
申请人 Hodous Brian L.;Liu-Bujalski Lesley;Jones Reinaldo;Bankston Donald;Johnson Theresa L.;Mochalkin Igor;Nguyen Ngan;Qiu Hui;Goutopoulos Andreas;Brugger Nadia 发明人 Hodous Brian L.;Liu-Bujalski Lesley;Jones Reinaldo;Bankston Donald;Johnson Theresa L.;Mochalkin Igor;Nguyen Ngan;Qiu Hui;Goutopoulos Andreas;Brugger Nadia
分类号 C07F5/02;C07D413/12;C07D401/12;C07D403/12;C07D239/47;C07D403/14;C07D403/04;C07D401/04;C07D451/02;C07D405/14;C07D413/14;C07D401/14;C07D471/10;C07D239/48 主分类号 C07F5/02
代理机构 代理人
主权项 1. A compound of formula I wherein X denotes CH or N, R1 denotes NH2, CONH2 or H, R2 denotes Hal, Ar1 or Het1, R3 denotes NR5[C(R5)2]nHet2, NR5[C(R5)2]nCyc, Het2, O[C(R5)2]nAr2, NR5[C(R5)2]nAr2, O[C(R5)2]nHet2, NR5(CH2)pNR5R6, O(CH2)pNR5R6 or NR5(CH2)pCR7R8NR5R6, R4 denotes H, CH3 or NH2, R5 denotes H or alkyl having 1, 2, 3 or 4 C atoms, R6 N(R5)2CH2CH═CHCONH, Het3CH2CH═CHCONH, CH2═CHCONH(CH2)n, Het4(CH2)nCOHet3-diyl-CH2CH═CHCONH, HC≡CCO, CH3C≡CCO, CH2═CH—CO, CH2═C(CH3)CONH, CH3CH═CHCONH(CH2)n, N≡CCR7R8CONH(CH2)n, Het4NH(CH2)pCOHet3-diyl-CH2CH═CHCONH, Het4(CH2)pCONH(CH2CH2O)p(CH2)pCOHet3-diyl-CH2CH═CHCONH, CH2═CHSO2, ACH═CHCO, CH3CH═CHCO, Het4(CH2)pCONH(CH2)pHet3-diyl-CH2CH═CHCONH, Ar3CH═CHSO2, CH2═CHSO2NH or N(R5)CH2CH═CHCO, R7, R8 denote together alkylene having 2, 3, 4, or 5 C atoms, Ar1 denotes phenyl or naphthyl, each of which is unsubstituted or mono-, di- or trisubstituted by R6, Hal, (CH2)nNH2, CONHAr3, (CH2)nNHCOA, O(CH2)nAr3, OCyc, A, COHet3, OA and/or OHet3 (CH2), Ar2 denotes phenyl, naphthyl or pyridyl each of which is unsubstituted or mono-, di- or trisubstituted by R6, Hal, OAr3, (CH2)nNH2, (CH2)nNHCOA and/or Het3, Ar3 denotes phenyl, which is unsubstituted or mono-, di- or trisubstituted by OH, OA, Hal, CN and/or A, Het1 denotes a mono- or bicyclic saturated, unsaturated or aromatic heterocycle having 1 to 4 N, O and/or S atoms, which may be unsubstituted or mono-, di- or trisubstituted by R6, O(CH2)nAr3 and/or (CH2)nAr3, Het2 denotes a mono- or bicyclic saturated heterocycle having 1 to 4 N, O and/or S atoms, which may be unsubstituted or mono-, di- or trisubstituted by R6, Het3, CycSO2, OH, Hal, COOH, OA, COA, COHet3, CycCO, SO2 and/or ═O, Het3 denotes a monocyclic unsaturated, saturated or aromatic heterocycle having 1 to 4 N, O and/or S atoms, which may be unsubstituted or mono-, di- or trisubstituted by Hal, A and/or ═O, Het4 denotes a bi- or tricyclic unsaturated, saturated or aromatic heterocycle having 1 to 4 N, O and/or S atoms, which may be unsubstituted or mono-, di-, tri- or tetrasubstituted by A, NO2, Hal and/or ═O, Cyc denotes cyclic alkyl having 3, 4, 5 or 6 C atoms, which is un-substituted, monosubstituted or disubstituted by R6 and/or OH and which may comprise a double bond, A denotes unbranched or branched alkyl having 1-10C atoms, in which 1-7H atoms may be replaced by F and/or Cl and/or in which one or two non-adjacent CH2 and/or CH-groups may be replaced by O, NH and/or by N, Hal denotes F, Cl, Br or I, n denotes 0, 1, 2, 3 or 4, p denotes 1, 2, 3, 4, 5 or 6, and pharmaceutically usable salts, tautomers and stereoisomers thereof, including mixtures thereof in all ratios.
地址 Cambridge MA US
您可能感兴趣的专利